As of 2025-08-18, the EV/EBITDA ratio of GW Pharmaceuticals PLC (GWPH) is
-125.15.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GWPH's latest enterprise value
is 6,464.12 mil USD. GWPH's TTM EBITDA according to its financial statements is
-51.65 mil USD. Dividing these 2
quantities gives us the above GWPH EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
- |
- |
| Forward P/E multiples |
40.2x - 40.2x |
40.2x |
| Fair Price |
219.09 - 219.09 |
219.09 |
| Upside |
0.1% - 0.1% |
0.1% |